Global Navigation
FDA report recognises need for improvement
A report from the US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has identified seven research and science needs that will help develop its regulatory science efforts.
The Identifying CDER's Science and Research Needs report recognises the need to develop, evaluate and/or improve: data and methods for the analyses of postmarket data; risk management strategies; scientific approaches to regulatory communications; product quality and performance; predictive models; design, analysis, and monitoring of clinical trials; and individualisation of patient treatment.
The report states: 'The seven categories constitute clearly identified major themes, but do not encompass every articulated need. As presented in this document, the needs have not been prioritised. The results are intended to serve as a framework for further steps to identify gaps and prioritise needs within the categories.'
The FDA has the report available to download.
Published: 26/07/2011
Content Area: Pharmaceutical industry articlesArticle type: Healthcare news
Jobs & Careers
Latest content
| PRA expands its European operations with new UK and Dutch offices |
| Daiichi to research cancer drugs with Japan’s National Cancer Centre |